For: | Higuera-de la Tijera F, Servín-Caamaño AI. Pathophysiological mechanisms involved in non-alcoholic steatohepatitis and novel potential therapeutic targets. World J Hepatol 2015; 7(10): 1297-1301 [PMID: 26052375 DOI: 10.4254/wjh.v7.i10.1297] |
---|---|
URL: | https://www.wjgnet.com/1948-5182/full/v7/i10/1297.htm |
Number | Citing Articles |
1 |
Agostino Di Ciaula, David Q-H Wang, Piero Portincasa. Cholesterol cholelithiasis: part of a systemic metabolic disease, prone to primary prevention. Expert Review of Gastroenterology & Hepatology 2019; 13(2): 157 doi: 10.1080/17474124.2019.1549988
|
2 |
Arpita Basu, Paramita Basu, Timothy J. Lyons. Biomarkers in Liver Disease. Biomarkers in Disease: Methods, Discoveries and Applications 2016; : 1 doi: 10.1007/978-94-007-7742-2_35-1
|
3 |
Fabiana de Faria Ghetti, Daiane Gonçalves Oliveira, Juliano Machado de Oliveira, Lincoln Eduardo Villela Vieira de Castro Ferreira, Dionéia Evangelista Cesar, Ana Paula Boroni Moreira. Influence of gut microbiota on the development and progression of nonalcoholic steatohepatitis. European Journal of Nutrition 2018; 57(3): 861 doi: 10.1007/s00394-017-1524-x
|
4 |
Lingxuan An, Ulrich Wirth, Dominik Koch, Malte Schirren, Moritz Drefs, Dionysios Koliogiannis, Hanno Nieß, Joachim Andrassy, Markus Guba, Alexandr V. Bazhin, Jens Werner, Florian Kühn. The Role of Gut-Derived Lipopolysaccharides and the Intestinal Barrier in Fatty Liver Diseases. Journal of Gastrointestinal Surgery 2022; 26(3): 671 doi: 10.1007/s11605-021-05188-7
|
5 |
Irineu O. M. Callegari, Guilherme Z. Rocha, Alexandre G. Oliveira. Physical exercise, health, and disease treatment: The role of macrophages. Frontiers in Physiology 2023; 14 doi: 10.3389/fphys.2023.1061353
|
6 |
Yolanda Sanchez-Torrijos, Javier Ampuero. NAFLD and NASH. 2020; : 1 doi: 10.1007/978-3-030-37173-9_1
|
7 |
Tian Shen, Bilin Xu, Tao Lei, Lin Chen, Cuiping Zhang, Zhenhua Ni. Sitagliptin reduces insulin resistance and improves rat liver steatosis via the SIRT1/AMPKα pathway. Experimental and Therapeutic Medicine 2018; doi: 10.3892/etm.2018.6554
|
8 |
J.M. Carrascosa, C. Bonanad, E. Dauden, R. Botella, A. Olveira-Martín. Psoriasis e hígado graso no alcohólico. Actas Dermo-Sifiliográficas 2017; 108(6): 506 doi: 10.1016/j.ad.2016.12.017
|
9 |
Jihan Xia, Leilei Xin, Wenjuan Zhu, Li Li, Chenxiao Li, Yanfang Wang, Yulian Mu, Shulin Yang, Kui Li. Characterization of long non-coding RNA transcriptome in high-energy diet induced nonalcoholic steatohepatitis minipigs. Scientific Reports 2016; 6(1) doi: 10.1038/srep30709
|
10 |
Yolanda Sánchez-Torrijos, Javier Ampuero Herrojo, Domingo Pérez Palacios, Rocío Gallego-Durán, Manuel Romero-Gómez. Analysis of the burden and variability in the management of NAFLD patients in the clinical practice: unifying the required criteria. Revista Española de Enfermedades Digestivas 2019; 111 doi: 10.17235/reed.2019.6088/2018
|
11 |
Marco Arrese, Daniel Cabrera, Alexis M. Kalergis, Ariel E. Feldstein. Innate Immunity and Inflammation in NAFLD/NASH. Digestive Diseases and Sciences 2016; 61(5): 1294 doi: 10.1007/s10620-016-4049-x
|
12 |
J.M. Carrascosa, C. Bonanad, E. Dauden, R. Botella, A. Olveira-Martín. Psoriasis and Nonalcoholic Fatty Liver Disease. Actas Dermo-Sifiliográficas (English Edition) 2017; 108(6): 506 doi: 10.1016/j.adengl.2017.05.017
|
13 |
Francisco Heine Ferreira Machado, Heladio Feitosa de Castro Filho, Rodrigo Feitosa de Albuquerque Lima Babadopulos, Hermano Alexandre Lima Rocha, Maria da Conceição Cavalcante Costa, José Lima de Carvalho Rocha, Manoel Odorico de Moraes Filho. Ursodeoxycholic acid in the prevention of gallstones in patients subjected to Roux-en-Y gastric bypass. Acta Cirurgica Brasileira 2019; 34(1) doi: 10.1590/s0102-865020190010000009
|
14 |
Leila Zarei, Negin Farhad, Ata Abbasi. All-Trans Retinoic Acid (atRA) effectively improves liver steatosis in a rabbit model of high fat induced liver steatosis. Archives of Physiology and Biochemistry 2022; 128(4): 1010 doi: 10.1080/13813455.2020.1743725
|
15 |
|
16 |
Xiangyun Tan, Yi Sun, Liang Chen, Junjie Hu, Yan Meng, Ming Yuan, Qi Wang, Shan Li, Guohua Zheng, Zhenpeng Qiu. Caffeine Ameliorates AKT-Driven Nonalcoholic Steatohepatitis by Suppressing De Novo Lipogenesis and MyD88 Palmitoylation. Journal of Agricultural and Food Chemistry 2022; 70(20): 6108 doi: 10.1021/acs.jafc.2c01013
|
17 |
Arpita Basu, Paramita Basu, Timothy J. Lyons. Biomarkers in Liver Disease. Biomarkers in Disease: Methods, Discoveries and Applications 2017; : 957 doi: 10.1007/978-94-007-7675-3_35
|
18 |
Bhagavathi Sundaram Sivamaruthi, Lim Ai Fern, Dk Siti Najwa Rashidah Pg Hj Ismail, Chaiyavat Chaiyasut. The influence of probiotics on bile acids in diseases and aging. Biomedicine & Pharmacotherapy 2020; 128: 110310 doi: 10.1016/j.biopha.2020.110310
|
19 |
Chao Li, Lihong Cui, Xiaohui Wang, Zhihui Yan, Shaoxin Wang, Yan Zheng. Using intestinal flora to distinguish non-alcoholic steatohepatitis from non-alcoholic fatty liver. Journal of International Medical Research 2020; 48(12) doi: 10.1177/0300060520978122
|
20 |
Kazim Sahin, Cemal Orhan, Fatih Akdemir, Mehmet Tuzcu, Nurhan Sahin, Ismet Yılmaz, Vijaya Juturu. β-Cryptoxanthin ameliorates metabolic risk factors by regulating NF-κB and Nrf2 pathways in insulin resistance induced by high-fat diet in rodents. Food and Chemical Toxicology 2017; 107: 270 doi: 10.1016/j.fct.2017.07.008
|
21 |
Stuart Astbury, Edmond Atallah, Amrita Vijay, Guruprasad P Aithal, Jane I Grove, Ana M Valdes. Lower gut microbiome diversity and higher abundance of proinflammatory genus Collinsella are associated with biopsy-proven nonalcoholic steatohepatitis. Gut Microbes 2020; 11(3): 569 doi: 10.1080/19490976.2019.1681861
|